Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,420.85
(
0.29%
)
News Focus
News Focus

Replies to post #243184 on Biotech Values

Replies to #243184 on Biotech Values
icon url

DewDiligence

07/12/22 11:21 PM

#243185 RE: DewDiligence #243184

p.s. Gene-therapy stocks have been huge losers over the past several years.
icon url

DewDiligence

07/13/22 9:59 AM

#243187 RE: DewDiligence #243184

AGTC -53% (eom).
icon url

DewDiligence

10/24/22 11:17 AM

#244269 RE: DewDiligence #243184

SYNC.L acquires AGTC for $0.34/sh cash—a 42% premium to Friday’s close:

https://www.globenewswire.com/news-release/2022/10/24/2539624/30580/en/Syncona-to-Acquire-Applied-Genetic-Technologies-Corporation.html

The buyout price of $0.34 is down 97%(!) from AGTC’s $12.00 IPO in 2014 (#msg-99596008).

The buyout includes a CVR worth up to $50M; excluding the CVR, the nominal deal value is $23.5M.